Bisphosphonate-associated scleritis: A case report and review

Research output: Contribution to journalArticle

Abstract

An 86-year-old female was treated for osteoporosis with alendronate, an aminobisphosphonate. Six weeks after alendronate therapy began, scleritis developed in the patient's right eye. The alendronate was discontinued, and, with the administration of prednisone, the symptoms of scleritis fully resolved. Rechallenge resulted in recurrence of the symptoms. Bisphosphonates are commonly used in the management of osteoporosis and are generally safe agents. Rarely, they have been linked with ocular inflammation. This case report reviews the literature on the ocular effects of bisphosphonates and discusses a possible mechanism for the association.

Original languageEnglish (US)
Pages (from-to)733-735
Number of pages3
JournalSouthern Medical Journal
Volume98
Issue number7
DOIs
StatePublished - Jul 2005

Fingerprint

Scleritis
Alendronate
Diphosphonates
Osteoporosis
Patient Rights
Prednisone
Inflammation
Recurrence
Therapeutics

Keywords

  • Alendronate
  • Bisphosphonate
  • Scleritis
  • Uveitis

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Bisphosphonate-associated scleritis : A case report and review. / Leung, Sophia; Ashar, Bimal; Miller, Redonda.

In: Southern Medical Journal, Vol. 98, No. 7, 07.2005, p. 733-735.

Research output: Contribution to journalArticle

@article{e88ce70cf8e14853905c02f82e4db6a0,
title = "Bisphosphonate-associated scleritis: A case report and review",
abstract = "An 86-year-old female was treated for osteoporosis with alendronate, an aminobisphosphonate. Six weeks after alendronate therapy began, scleritis developed in the patient's right eye. The alendronate was discontinued, and, with the administration of prednisone, the symptoms of scleritis fully resolved. Rechallenge resulted in recurrence of the symptoms. Bisphosphonates are commonly used in the management of osteoporosis and are generally safe agents. Rarely, they have been linked with ocular inflammation. This case report reviews the literature on the ocular effects of bisphosphonates and discusses a possible mechanism for the association.",
keywords = "Alendronate, Bisphosphonate, Scleritis, Uveitis",
author = "Sophia Leung and Bimal Ashar and Redonda Miller",
year = "2005",
month = "7",
doi = "10.1097/01.SMJ.0000152753.80490.9F",
language = "English (US)",
volume = "98",
pages = "733--735",
journal = "Southern Medical Journal",
issn = "0038-4348",
publisher = "Lippincott Williams and Wilkins",
number = "7",

}

TY - JOUR

T1 - Bisphosphonate-associated scleritis

T2 - A case report and review

AU - Leung, Sophia

AU - Ashar, Bimal

AU - Miller, Redonda

PY - 2005/7

Y1 - 2005/7

N2 - An 86-year-old female was treated for osteoporosis with alendronate, an aminobisphosphonate. Six weeks after alendronate therapy began, scleritis developed in the patient's right eye. The alendronate was discontinued, and, with the administration of prednisone, the symptoms of scleritis fully resolved. Rechallenge resulted in recurrence of the symptoms. Bisphosphonates are commonly used in the management of osteoporosis and are generally safe agents. Rarely, they have been linked with ocular inflammation. This case report reviews the literature on the ocular effects of bisphosphonates and discusses a possible mechanism for the association.

AB - An 86-year-old female was treated for osteoporosis with alendronate, an aminobisphosphonate. Six weeks after alendronate therapy began, scleritis developed in the patient's right eye. The alendronate was discontinued, and, with the administration of prednisone, the symptoms of scleritis fully resolved. Rechallenge resulted in recurrence of the symptoms. Bisphosphonates are commonly used in the management of osteoporosis and are generally safe agents. Rarely, they have been linked with ocular inflammation. This case report reviews the literature on the ocular effects of bisphosphonates and discusses a possible mechanism for the association.

KW - Alendronate

KW - Bisphosphonate

KW - Scleritis

KW - Uveitis

UR - http://www.scopus.com/inward/record.url?scp=23044479731&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=23044479731&partnerID=8YFLogxK

U2 - 10.1097/01.SMJ.0000152753.80490.9F

DO - 10.1097/01.SMJ.0000152753.80490.9F

M3 - Article

C2 - 16108245

AN - SCOPUS:23044479731

VL - 98

SP - 733

EP - 735

JO - Southern Medical Journal

JF - Southern Medical Journal

SN - 0038-4348

IS - 7

ER -